Clinical Trial Update: Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated bevacizumab with temozolomide or bevacizumab with nab-paclitaxel and carboplatin in patients with stage IV malignant melanoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (Abraxane) (nab-paclitaxel)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2018-05-01